Core Viewpoint - Origin Materials, Inc. announced its financial results for the third quarter ended September 30, 2025, highlighting a financing initiative aimed at strengthening its balance sheet and providing access to additional capital for future growth [1]. Financial Performance - The company reported its financial results for Q3 2025, indicating a focus on sustainable materials and the transition towards them [1]. Strategic Initiatives - Origin Materials is pursuing financing that will enhance its financial stability and enable further capital access, which is crucial for its operational and strategic objectives [1].

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Origin Materials, Inc. (NASDAQ: ORGN) breached their fiduciary duties to shareholders. If you currently own Origin stock and acquired shares on or before February 23, 2023, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to lea. ...

Core Insights - The company is addressing investor concerns regarding its ability to survive until profitability, indicating a focus on long-term sustainability and growth [1] - There is an emphasis on upcoming developments in the next few months, suggesting potential positive changes that could impact stock performance [1] Group 1 - The company is confident in its survival until profitability, which is a critical concern for investors [1] - There is anticipation for the stock price to exceed $1 in the near future, reflecting investor optimism [1]

Financial Data and Key Metrics Changes - The company announced a reduction in manufacturing output estimates by approximately 50-15% for 2026 and 2027 compared to prior estimates due to delays in cap former factory acceptance testing [19] - Updated revenue guidance for 2026 is now $20 million to $30 million, and for 2027, it is $100 million to $200 million, down from previous estimates of $50 million to $70 million and $150 million to $210 million respectively [20] - The company ended the quarter with $69 million in cash, cash equivalents, and marketable securities, alongside a net accounts receivable balance of $17.9 million [20][21] Business Line Data and Key Metrics Changes - The first Origin PET bottle caps are now on store shelves, marking a significant milestone for the company and the packaging industry [6] - The company is focusing on five large functional segments within the $65 billion caps and closures market, including water, carbonated soft drinks, other beverage applications, food and pharmaceutical, and other non-beverage segments [10] Market Data and Key Metrics Changes - The company is targeting a $7 billion segment for non-carbonated water caps and a $6 billion segment for carbonated soft drinks [10] - The packaging industry is described as highly commoditized and competitive, with a noted lack of innovation [9] Company Strategy and Development Direction - The company is conducting a strategic review with RBC Capital Markets to identify strategies that can enhance access to manufacturing capacity and strategic capital [10] - A refinement of the go-to-market strategy has been initiated to prioritize high-value opportunities within the caps and closures market [10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the impact of tariffs on production costs and the need for strategic partnerships to mitigate these challenges [18] - The company remains optimistic about its growth potential, citing strong interest in its products and ongoing customer relationships [42] Other Important Information - The company has established a partnership with Berlin Packaging, which will help extend market reach for its PET caps [12] - The company is expanding its manufacturing capacity in Europe to respond to tariff pressures and enhance production capabilities [15] Q&A Session All Questions and Answers Question: Where can investors buy the product to support it? - The product is available on shelves with a small brand, Power Hydration, located in California [27] Question: Who are the closest competitors and how does Origin compare? - The company's technology is differentiated from existing PET cap production methods, allowing for better unit economics and material properties [29][30] Question: What is the status of the NASDAQ listing? - The company is currently in a grace period to meet the minimum stock price requirement and is optimistic about regaining compliance [36][39] Question: What should investors be excited about for the future? - The company is excited about the market introduction of its PET bottle caps and ongoing customer announcements, alongside strategic growth opportunities [41][43]

Financial Highlights - Origin Materials projects revenue of $20 million to $30 million in 2026[8] and $100 million to $200 million in 2027[8, 15] - The company anticipates achieving Adjusted EBITDA positive run rate in 2027[8, 15] - Manufacturing lines are expected to have a payback period of less than 18 months[12, 13] Market and Demand - The total addressable market for Origin closures is greater than $65 billion[8, 32, 57] - The company is currently in the $7 billion water market segment[56, 57] and is qualifying for the $6 billion carbonated soft drink (CSD) market[57, 60] - Demand currently exceeds projected manufacturing capacity for the foreseeable future[6, 72] Manufacturing and Technology - Origin Materials commenced production on its first CapFormer line in February 2025[17, 60] - The company is on track to have 8 to 10 CapFormer lines in operation in 2026[15, 17] - Origin Materials has secured over 70 patents protecting its technology and products[9, 75]

[PART I. — FINANCIAL INFORMATION](index=4&type=section&id=PART%20I.%20%E2%80%94%20FINANCIAL%20INFORMATION) This section presents the unaudited financial statements and management's analysis of the company's financial performance and condition [Item 1. Condensed Consolidated Financial Statements (unaudited)](index=4&type=section&id=Item%201.%20Condensed%20Consolidated%20Financial%20Statements%20(unaudited)) The company reported an increased net loss and decreased total assets, with significant 'going concern' risk due to funding needs [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets decreased to **$348.4 million** by June 30, 2025, driven by reduced cash and marketable securities, while equity declined due to net loss Condensed Consolidated Balance Sheet Data (in thousands) | Account | June 30, 2025 (Unaudited) | December 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $35,295 | $56,307 | | Marketable securities | $34,106 | $46,613 | | Total current assets | $101,584 | $139,174 | | Property, plant, and equipment, net | $229,068 | $203,919 | | **Total assets** | **$348,377** | **$378,027** | | **Liabilities & Equity** | | | | Total current liabilities | $15,941 | $12,549 | | **Total liabilities** | **$37,251** | **$39,662** | | Accumulated deficit | ($77,315) | ($38,127) | | **Total stockholders' equity** | **$311,126** | **$338,365** | [Condensed Consolidated Statements of Operations and Comprehensive Loss](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations%20and%20Comprehensive%20Loss) Total revenues decreased by **19%** to **$11.2 million**, resulting in an increased net loss of **$39.2 million** due to an asset impairment charge Statement of Operations Highlights (in thousands, except per share data) | Metric | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Total revenues | $11,243 | $13,858 | | Loss from operations | ($47,589) | ($36,254) | | Impairment of assets | $16,610 | $0 | | **Net loss** | **($39,188)** | **($33,412)** | | Net loss per share, basic & diluted | ($0.27) | ($0.23) | [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash used in operating activities improved to **$15.7 million**, though overall cash and equivalents decreased by **$21.0 million** to **$35.3 million** Cash Flow Summary (in thousands) | Activity | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Net cash used in operating activities | ($15,733) | ($31,697) | | Net cash (used in) provided by investing activities | ($665) | $2,205 | | Net cash (used in) provided by financing activities | ($4,485) | $6,806 | | **Net decrease in cash and cash equivalents** | **($21,012)** | **($19,818)** | | **Cash and cash equivalents end of the period** | **$35,295** | **$55,684** | [Notes to Unaudited Condensed Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) Notes highlight a 'going concern' warning due to recurring losses and an accumulated deficit, alongside a **$16.6 million** asset impairment charge - The company has a 'going concern' warning due to its financial condition, including **$69.4 million** in cash and marketable securities, an accumulated deficit of **$77.3 million**, and recurring net losses. Management states these conditions raise substantial doubt about the company's ability to continue for the next twelve months[26](index=26&type=chunk) - During the first six months of 2025, the company recorded a **$16.6 million** impairment charge after terminating an agreement for materials conversion. This was related to discharging advance payments and future commitments under a take-or-pay agreement[44](index=44&type=chunk)[101](index=101&type=chunk) - The company is involved in a putative securities class action and two shareholder derivative complaints related to its August 9, 2023 announcement about delays in its Origin 2 project. The company cannot predict the outcome or financial impact at this preliminary stage[106](index=106&type=chunk)[107](index=107&type=chunk)[108](index=108&type=chunk) - The company has purchase commitments for equipment for its PET closures business totaling approximately **$22.4 million**, subject to milestone achievements. As of June 30, 2025, payments of **$27.1 million** had already been made[99](index=99&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=29&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses decreased revenue, a strategic review for shareholder value, and reiterates the 'going concern' risk without additional financing - In August 2025, the Board initiated a broad strategic review to maximize shareholder value, considering alternatives such as a business combination, asset divestiture, technology licensing, merger, or sale of the company[121](index=121&type=chunk) - The company faces substantial doubt about its ability to continue as a going concern. Absent substantial additional financing by the end of 2025, management expects to begin scaling back or ceasing certain operations and reducing headcount[159](index=159&type=chunk)[162](index=162&type=chunk) - The company experienced delays in its CapFormer lines build-out due to slower subcomponent delivery and tariffs, leading to an expected substantial reduction in manufacturing output for 2026[127](index=127&type=chunk) [Results of Operations](index=33&type=section&id=Results%20of%20Operations) Revenues decreased **19%** to **$11.2 million**, while operating expenses rose **31%** due to a **$16.6 million** asset impairment charge Comparison of Six Months Ended June 30, 2025 and 2024 (in thousands) | Line Item | 2025 | 2024 | Variance $ | Variance % | | :--- | :--- | :--- | :--- | :--- | | Total revenues | $11,243 | $13,858 | ($2,615) | (19)% | | Research and development | $6,579 | $10,211 | ($3,632) | (36)% | | General and administrative | $19,199 | $21,264 | ($2,065) | (10)% | | Impairment of assets | $16,610 | $0 | $16,610 | 100% | | Loss from operations | ($47,589) | ($36,254) | ($11,335) | 31% | | Net loss | ($39,188) | ($33,412) | ($5,776) | 17% | [Liquidity, Capital Resources and Going Concern](index=37&type=section&id=Liquidity%2C%20Capital%20Resources%20and%20Going%20Concern) The company holds **$69.4 million** in liquidity but faces substantial 'going concern' doubt, requiring significant additional capital for its growth strategy - The company's liquidity position as of June 30, 2025, was **$69.4 million** in cash, cash equivalents, and marketable securities[158](index=158&type=chunk) - Management has concluded there is substantial doubt about the company's ability to continue as a going concern for a period of twelve months from the issuance of the financial statements[159](index=159&type=chunk) - The company requires substantial additional project financing to execute its growth strategy, particularly for its PET closures manufacturing lines, and is evaluating strategies including equity, debt, and strategic partnerships[160](index=160&type=chunk)[162](index=162&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=40&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company is a 'smaller reporting company' and is therefore not required to provide the information requested under this item - As a 'smaller reporting company,' Origin Materials is not required to provide quantitative and qualitative disclosures about market risk[174](index=174&type=chunk) [Item 4. Controls and Procedures](index=40&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of June 30, 2025, with no material changes to internal controls - Management concluded that as of June 30, 2025, the company's disclosure controls and procedures were effective at the reasonable assurance level[176](index=176&type=chunk) - No material changes to the company's internal control over financial reporting occurred during the six months ended June 30, 2025[177](index=177&type=chunk) [PART II. — OTHER INFORMATION](index=41&type=section&id=PART%20II.%20%E2%80%94%20OTHER%20INFORMATION) This section covers legal proceedings, risk factors, and other miscellaneous disclosures relevant to the company's operations [Item 1. Legal Proceedings](index=41&type=section&id=Item%201.%20Legal%20Proceedings) The company is defending against a securities class action and shareholder derivative complaints related to Origin 2 project delays - The company is defending against a securities class action lawsuit and two shareholder derivative complaints related to its August 2023 announcement of delays to the Origin 2 project[106](index=106&type=chunk)[107](index=107&type=chunk)[179](index=179&type=chunk) [Item 1A. Risk Factors](index=41&type=section&id=Item%201A.%20Risk%20Factors) Key risks include 'going concern' doubt, history of losses, commercialization challenges, supply chain issues, and potential Nasdaq delisting - There is substantial doubt about the company's ability to continue as a going concern, and a failure to obtain necessary capital may force it to delay, limit, or terminate operations[180](index=180&type=chunk)[182](index=182&type=chunk) - The company has a history of losses, its future profitability is uncertain, and it has not yet produced any of its products in large commercial quantities[180](index=180&type=chunk)[187](index=187&type=chunk)[203](index=203&type=chunk) - The company's common stock is at risk of being delisted from Nasdaq for failing to meet the minimum **$1.00** bid price requirement, which could adversely affect liquidity and its ability to raise capital[184](index=184&type=chunk)[331](index=331&type=chunk) - International trade disputes and tariffs, particularly on goods from Europe and Switzerland, are increasing the cost of capital equipment (CapFormers) and could adversely affect the business[268](index=268&type=chunk)[270](index=270&type=chunk)[271](index=271&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=71&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) There were no unregistered sales of equity securities during the reporting period - None[343](index=343&type=chunk) [Item 3. Defaults Upon Senior Securities](index=71&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) There were no defaults upon senior securities during the reporting period - None[344](index=344&type=chunk) [Item 4. Mine Safety Disclosures](index=71&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company - Not applicable[345](index=345&type=chunk) [Item 5. Other Information](index=71&type=section&id=Item%205.%20Other%20Information) General Counsel Joshua Lee's Rule 10b5-1 stock trading plan, initiated in September 2024, was terminated in June 2025 - On September 13, 2024, General Counsel Joshua Lee entered into a Rule 10b5-1 stock trading plan for the sale of up to **60,000** shares. This plan was terminated on June 9, 2025[346](index=346&type=chunk) [Item 6. Exhibits](index=72&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including corporate governance documents and officer certifications

[Management Commentary and Strategic Update](index=1&type=section&id=Management%20Commentary%20and%20Strategic%20Update) CEO John Bissell highlights the commercial launch of Origin PET bottlecaps and a strategic review to accelerate value capture and address capacity gaps - The first Origin PET bottlecaps are now on store shelves, a world's first for the company, initially targeting the **$7 billion** non-carbonated water market[2](index=2&type=chunk) - Announced Berlin Packaging, the world's largest Hybrid Packaging Supplier®, as its first publicly named customer for PET 1881 caps[2](index=2&type=chunk)[6](index=6&type=chunk) - Launched a strategic review with financial advisor RBC Capital Markets to explore opportunities for enhancing manufacturing capacity, distribution, and access to strategic capital[3](index=3&type=chunk) - Refined its go-to-market strategy to prioritize five large market segments: water (**$7B**), carbonated soft drinks (**$6B**), other beverages (**$18B**), non-beverage food/pharma (**$20B**), and other non-beverage (**$17B**)[3](index=3&type=chunk) [Manufacturing and Supply Chain Update](index=2&type=section&id=Manufacturing%20and%20Supply%20Chain%20Update) The company faces manufacturing delays and increased capital needs due to tariffs, leading to a new European production partnership - Factory Acceptance Testing (FAT) completion for CapFormer lines two through eight is expected to be delayed by **30 to 90 days** due to OEM manufacturing and procurement issues[2](index=2&type=chunk)[6](index=6&type=chunk) - FAT for CapFormers seven and eight is now planned for the **second half of 2026**, revised from Q1 2026, primarily due to capital constraints and tariff exposure[6](index=6&type=chunk) - Announced a new European mass production partnership with Royal Hordijk to diversify manufacturing, expand its global footprint, and mitigate U.S. tariff impacts on European imports[6](index=6&type=chunk) - The company faces increased capital requirements due to tariffs on CapFormer subsystems sourced from Europe, with a **15% tariff** on EU imports and a **39% tariff** on Switzerland imports[7](index=7&type=chunk) [Revised 2026-2027 Financial Guidance](index=4&type=section&id=Revised%202026-2027%20Financial%20Guidance) Revised 2026-2027 revenue guidance and pushed Adjusted EBITDA breakeven to 2027 due to CapFormer delays Revised Guidance | Guidance Metric | Prior Guidance (Millions USD) | Updated Guidance (Millions USD) | | :--- | :--- | :--- | | **2026 Revenue** | $50M - $70M | $20M - $30M | | **2027 Revenue** | $150M - $210M | $100M - $200M | - The Adjusted EBITDA run-rate breakeven target has been pushed from **2026 into 2027** due to production delays[7](index=7&type=chunk) [Second Quarter 2025 Financial Performance](index=5&type=section&id=Results%20for%20Second%20Quarter%202025) Q2 2025 revenue decreased to $5.8 million, while net loss and Adjusted EBITDA loss significantly narrowed year-over-year Q2 Financial Performance | Metric | Q2 2025 (Millions USD) | Q2 2024 (Millions USD) | | :--- | :--- | :--- | | Revenue | $5.8 million | $7.0 million | | Operating Expenses | $15.1 million | $18.5 million | | Net Loss | $12.7 million | $19.5 million | | Adjusted EBITDA Loss | $9.9 million | $12.9 million | - As of June 30, 2025, the company held **$69.4 million** in cash, cash equivalents, and marketable securities[8](index=8&type=chunk) - The company identified significant future cash sources, including the collection of **$17.9 million** in net accounts receivable and the sale of **$9.0 million** in land held for sale[8](index=8&type=chunk)[9](index=9&type=chunk) [Financial Statements](index=11&type=section&id=Financial%20Statements) This section provides detailed unaudited condensed consolidated financial statements for the period ended June 30, 2025 [Condensed Consolidated Balance Sheets](index=11&type=section&id=CONDENSED%20CONSOLIDATED%20BALANCE%20SHEETS) This section details the company's financial position, including assets, liabilities, and equity, as of June 30, 2025 Balance Sheet Summary | Balance Sheet Item | June 30, 2025 (in thousands) | December 31, 2024 (in thousands) | | :--- | :--- | :--- | | **Total Current Assets** | $101,584 | $139,174 | | Property, plant, and equipment, net | $229,068 | $203,919 | | **Total Assets** | **$348,377** | **$378,027** | | **Total Current Liabilities** | $15,941 | $12,549 | | **Total Liabilities** | $37,251 | $39,662 | | **Total Stockholders' Equity** | $311,126 | $338,365 | [Condensed Consolidated Statements of Operations](index=12&type=section&id=CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20OPERATIONS%20AND%20COMPREHENSIVE%20LOSS) This section outlines the company's revenues, expenses, and net loss for the three months ended June 30, 2025, and 2024 Income Statement Summary | Income Statement Item (Three Months Ended June 30) | 2025 (in thousands) | 2024 (in thousands) | | :--- | :--- | :--- | | Total Revenues | $5,813 | $7,033 | | Total Operating Expenses | $15,148 | $18,464 | | Loss from Operations | $(14,966) | $(18,257) | | **Net Loss** | **$(12,747)** | **$(19,499)** | | **Net Loss Per Share, basic & diluted** | **$(0.09)** | **$(0.14)** | [Condensed Consolidated Statements of Cash Flows](index=13&type=section&id=CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20CASH%20FLOWS) This section details cash flows from operating, investing, and financing activities for the six months ended June 30, 2025, and 2024 Cash Flow Summary | Cash Flow Item (Six Months Ended June 30) | 2025 (in thousands) | 2024 (in thousands) | | :--- | :--- | :--- | | Net cash used in operating activities | $(15,733) | $(31,697) | | Net cash (used in) provided by investing activities | $(665) | $2,205 | | Net cash (used in) provided by financing activities | $(4,485) | $6,806 | | **Net decrease in cash and cash equivalents** | **$(21,012)** | **$(19,818)** | | **Cash and cash equivalents end of the period** | **$35,295** | **$55,684** | [Reconciliation of GAAP to Non-GAAP Measures](index=15&type=section&id=Reconciliation%20of%20GAAP%20and%20Non-GAAP%20Results) This section reconciles GAAP Net Loss to non-GAAP Adjusted EBITDA for the three months ended June 30, 2025, and 2024 GAAP to Non-GAAP Reconciliation | Reconciliation (Three Months Ended June 30) | 2025 (in thousands) | 2024 (in thousands) | | :--- | :--- | :--- | | **Net loss (GAAP)** | **$(12,747)** | **$(19,499)** | | Stock-based compensation | $2,280 | $2,536 | | Depreciation and amortization | $2,782 | $2,813 | | Other adjustments | $(1,221) | $1,238 | | **Adjusted EBITDA (Non-GAAP)** | **$(9,904)** | **$(12,908)** |

Group 1 - FDCA is a high-value bio-based compound with a wide range of applications, serving as a substitute for terephthalic acid and enabling the production of high-performance bio-based polymers [2][8] - The synthesis routes for FDCA are diverse, with the HMF route being the most promising and showing significant progress towards industrial production [17][18] - The global FDCA market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2028, potentially reaching $873.28 million by 2028 [4][51] Group 2 - Internationally, several companies have achieved FDCA production, with significant investments made since 2004, including major players like Coca-Cola, DuPont, and Avantium [3][35] - Domestic research on FDCA began around 2010 and has rapidly advanced, with notable breakthroughs in synthesis and polymerization processes [3][41] - The domestic industry is still in its early stages of commercialization, but there is a growing number of patents and publications, indicating a strong research foundation [3][41] Group 3 - PEF, derived from FDCA and ethylene glycol, exhibits superior properties compared to PET, including higher mechanical strength and better gas barrier performance, making it a promising alternative [5][10] - The application areas for PEF include food packaging, films, and fibers, with significant potential for replacing PET in various markets [5][10] - The production of PEF is expected to expand, driven by the increasing demand for sustainable materials and the growth of the bio-based product market [5][51] Group 4 - Companies like Avantium and Eastman are leading the way in FDCA production technology, with Avantium's YXY technology being a notable example [36][39] - Domestic companies such as Hefei Lif Biological and Zhongke Guosheng are making strides in FDCA production, with innovative processes and significant production capacity planned for the near future [44][45] - The collaboration between research institutions and companies is fostering innovation and accelerating the commercialization of FDCA and its derivatives in China [41][44]

Investment Rating - The report maintains a rating of "Overweight" for the FDCA industry [7] Core Insights - FDCA is a high-value bio-based compound with a wide range of applications, particularly in the production of PEF, which has significant market potential [1][3][5] - The global FDCA market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2028, potentially reaching USD 873.28 million by 2028 [3] - PEF, derived from FDCA, exhibits superior properties compared to PET, making it a promising alternative in various applications [4][5] Summary by Sections FDCA Overview - FDCA is a bio-based aromatic monomer derived from biomass such as starch and cellulose, recognized as a suitable substitute for terephthalic acid [1][14] - The synthesis routes for FDCA include chemical and biological methods, with the HMF route being the most promising for industrialization [1][26][27] Domestic and International Development - Internationally, several companies have achieved FDCA production since 2004, while domestic efforts began around 2010 and are rapidly advancing [2][45][56] - Notable international players include Avantium, Corbion Purac, and DuPont, which have made significant strides in FDCA and PEF research and production [45][46][48] Market Potential and Applications - The FDCA market is projected to exceed USD 1.13 billion by 2031, driven by increasing demand for bio-based products [3] - PEF's applications span food packaging, films, and fibers, with its oxygen and carbon dioxide barrier properties significantly outperforming PET [4][18][19] Investment Recommendations - The report suggests focusing on companies involved in FDCA production, such as Tongkun Co., New Fengming, and Zhenhai Refining & Chemical [5][58][60]

Financial Data and Key Metrics Changes - The company expects to realize revenue of $50 million to $70 million in 2026 and $150 million to $210 million in 2027, reflecting a delay in commercial scale PET cap revenue generation by one to three quarters [9][19] - The company ended the quarter with $83 million in cash, cash equivalents, and marketable securities, indicating a strong balance sheet [20] Business Line Data and Key Metrics Changes - The company is commercializing its PET cap solution, which addresses a $65 billion cap closures market, with over 20 companies qualifying or preparing for qualification [6][13] - The qualification process for PET caps is taking longer than expected, with a typical journey now projected to take one to two years [10][12] Market Data and Key Metrics Changes - The company is facing challenges due to global manufacturing supply chain disruptions caused by tariffs and protectionist trade policies [13][14] - The company is diversifying its manufacturing footprint to minimize tariff exposure and ensure supply meets demand in different regions [17] Company Strategy and Development Direction - The company is focused on enabling the transition to sustainable materials and is committed to overcoming qualification challenges to bring PET caps to market [22][60] - The company is investing in supply chain preparedness and proactive inventory strategies to limit disruptions [15][16] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about customer interest, with over 65 new inquiries in the last six weeks, and believes qualification challenges will be overcome [22][60] - The company is confident in its ability to achieve run rate positive adjusted EBITDA by the end of 2026, with a focus on scaling production [19][20] Other Important Information - The company has signed a strategic customer agreement with a major packaging company for the development of large format PET closures [6] - The company is exploring additional technology improvements to increase line throughput [18] Q&A Session All Questions and Answers Question: Why is your revenue declining further? - The company is operating OriginOne intermittently to supply customers with samples and develop internal process knowledge, turning down the operating rate to allocate cash more prudently [28] Question: Are there any specific issues faced in product qualification? - The qualification process has shown variability among customers, requiring iterative changes to meet performance standards [30][32] Question: Can you provide an update on EBITDA breakeven and higher CapEx due to tariffs? - The company has factored in a 10% tariff on equipment and does not expect it to materially impact the return on invested capital or the ability to stand up the planned lines [34] Question: What details can you provide on new caps available in Q3? - The new caps expected to be H-91 caps have been specified, but details on the specific region will be shared once they are in the market [35] Question: Any update on the sales process for the 83-acre lot in Geismar? - The company has sold 35 of the 80 acres and remains optimistic about the remaining portion [38] Question: What is the status of the $100 million MOU? - The MOU is still in place and will convert into a contract once the first lot of product is shipped post-qualification [51] Question: When will revenue realization begin? - Revenue ramp is expected to begin in mid-2026, with customers qualifying within one to three quarters [53][54] Question: How does the company plan to fund growth? - The company is engaged with multiple equipment lenders for financing and is also sourcing corporate debt to cover any balance needed [56][58] Question: What should investors be excited about in the future? - The company is excited about the strong demand for its caps, with significant customer interest and new agreements in the pipeline [60][61]